Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., . . . Herrmann, R. P. (2014). A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy. Clinical gastroenterology and hepatology, 12(1), 64-71. https://doi.org/10.1016/j.cgh.2013.06.021
Chicago Style (17th ed.) CitationForbes, Geoffrey M., Marian J. Sturm, Rupert W. Leong, Miles P. Sparrow, Dev Segarajasingam, Adrian G. Cummins, Michael Phillips, and Richard P. Herrmann. "A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy." Clinical Gastroenterology and Hepatology 12, no. 1 (2014): 64-71. https://doi.org/10.1016/j.cgh.2013.06.021.
MLA (9th ed.) CitationForbes, Geoffrey M., et al. "A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy." Clinical Gastroenterology and Hepatology, vol. 12, no. 1, 2014, pp. 64-71, https://doi.org/10.1016/j.cgh.2013.06.021.